AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
SHORT-COURSE INFUSIONAL IDARUBICIN PLUS INTERMITTENT CYTARABINE AND ETOPOSIDE FOR REFRACTORY HEMATOLOGIC MALIGNANCIES - CLINICAL AND PRELIMINARY PHARMACOLOGICAL RESULTS
Authors: BASSAN R CHIODINI B ZUCCHETTI M LEREDE T CORNELLI PE CORTELAZZO S BARBUI J
Citation: R. Bassan et al., SHORT-COURSE INFUSIONAL IDARUBICIN PLUS INTERMITTENT CYTARABINE AND ETOPOSIDE FOR REFRACTORY HEMATOLOGIC MALIGNANCIES - CLINICAL AND PRELIMINARY PHARMACOLOGICAL RESULTS, Haematologica, 83(1), 1998, pp. 27-33
ASPIRIN INCREASES THE BLEEDING SIDE-EFFECTS IN ESSENTIAL THROMBOCYTHEMIA INDEPENDENT OF THE CYCLOOXYGENASE PATHWAY - ROLE OF THE LIPOXYGENASE PATHWAY
Authors: CORTELAZZO S MARCHETTI M ORLANDO E FALANGA A BARBUI T BUCHANAN MR
Citation: S. Cortelazzo et al., ASPIRIN INCREASES THE BLEEDING SIDE-EFFECTS IN ESSENTIAL THROMBOCYTHEMIA INDEPENDENT OF THE CYCLOOXYGENASE PATHWAY - ROLE OF THE LIPOXYGENASE PATHWAY, American journal of hematology, 57(4), 1998, pp. 277-282
BEAM CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION AS FRONT-LINE THERAPY FOR HIGH-RISK PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA
Authors: CORTELAZZO S ROSSI A VIERO P BELLAVITA P MARCHIOLI R MARFISI RM RAMBALDI A BARBUI T
Citation: S. Cortelazzo et al., BEAM CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION AS FRONT-LINE THERAPY FOR HIGH-RISK PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA, British Journal of Haematology, 99(2), 1997, pp. 379-385
LOW-DOSE ASPIRIN IN POLYCYTHEMIA-VERA - A PILOT-STUDY
Authors: BARBUI T DEGAETANO G FINAZZI G LANDOLFI R MARCHIOLI R PATRONO C TOGNONI G CAPANI F DECARLI A GAMBI D NENCI GG TURA S MANDELLI F ROSSIFERRINI P CORTELAZZO S VESTRI O FINELLI C NOCENTINI F POGLIANI EM MICCOLIS IR BIZZI B ROCCA B TARTAGILIONE R ANGELI G DIBLASIO A DIPASQUALE A KRAMER V MARFISI RM OLIVIERI M SCIULLI L SPOLTORE R MONTEFUSCO E SPADEA A CAROTENUTO M NOBILE M MORELLI A RESEGOTTI L VASINO MAC RODEGHIERO F RUGGERI M
Citation: T. Barbui et al., LOW-DOSE ASPIRIN IN POLYCYTHEMIA-VERA - A PILOT-STUDY, British Journal of Haematology, 97(2), 1997, pp. 453-456
LONG-TERM HEMATOLOGICAL RECONSTITUTION FOLLOWING BEAM AND AUTOLOGOUS TRANSPLANTATION OF CIRCULATING PROGENITOR CELLS IN NON-HODGKINS-LYMPHOMA
Authors: ROSSI A CORTELAZZO S BELLAVITA P VIERO P BASSAN R COMOTTI B MARCHIOLI R MARFISI RM RAMBALDI A BARBUI T
Citation: A. Rossi et al., LONG-TERM HEMATOLOGICAL RECONSTITUTION FOLLOWING BEAM AND AUTOLOGOUS TRANSPLANTATION OF CIRCULATING PROGENITOR CELLS IN NON-HODGKINS-LYMPHOMA, British Journal of Haematology, 96(3), 1997, pp. 620-626
BEAM CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION AS FRONT-LINE THERAPY OF HIGH-RISK PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA AND UNFAVORABLE CLINICAL PRESENTATION
Authors: CORTELAZZO S ROSSI A RAMBALDI A BARBUI T
Citation: S. Cortelazzo et al., BEAM CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION AS FRONT-LINE THERAPY OF HIGH-RISK PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMA AND UNFAVORABLE CLINICAL PRESENTATION, Blood, 90(10), 1997, pp. 498-498
C-CSF-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION OF RESISTANT OR RELAPSING ACUTE LEUKEMIAS
Authors: RAMBALDI A VIERO P BASSAN R BUELLI M ROSSI A BELLAVITA P SPINELLI O AMARU R MICHELETTI M BORLERI G CORTELAZZO S COMOTTI B BARBUI T
Citation: A. Rambaldi et al., C-CSF-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION OF RESISTANT OR RELAPSING ACUTE LEUKEMIAS, Leukemia, 10(5), 1996, pp. 860-865
THERAPEUTIC IMPACT OF ADULT-TYPE ACUTE LYMPHOBLASTIC-LEUKEMIA REGIMENS IN B-CELL L(3) ACUTE-LEUKEMIA AND ADVANCED-STAGE BURKITTS-LYMPHOMA/
Authors: LEREDE T BASSAN R ROSSI A DIBONA E ROSSI G POGLIANI EM MOTTA T TORRI V BUELLI M COMOTTI B VIERO P RAMBALDI A CORTELAZZO S RODEGHIERO F BARBUI T
Citation: T. Lerede et al., THERAPEUTIC IMPACT OF ADULT-TYPE ACUTE LYMPHOBLASTIC-LEUKEMIA REGIMENS IN B-CELL L(3) ACUTE-LEUKEMIA AND ADVANCED-STAGE BURKITTS-LYMPHOMA/, Haematologica, 81(5), 1996, pp. 442-449
FACTORS FOR RAPID AND SUSTAINED HEMATOPOIETIC RECONSTITUTION BY CIRCULATING PROGENITOR-CELL TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA
Authors: BARBUI T CORTELAZZO S ROSSI A VIERO P BELLAVITA P BUELLI M FRACASSETTI D BASSAN R COMOTTI B MARCHIOLI R MARFISI RM RAMBALDI A
Citation: T. Barbui et al., FACTORS FOR RAPID AND SUSTAINED HEMATOPOIETIC RECONSTITUTION BY CIRCULATING PROGENITOR-CELL TRANSPLANTATION IN NON-HODGKINS-LYMPHOMA, Cancer chemotherapy and pharmacology, 38, 1996, pp. 110-114
EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ON THE RATE OF NEUTROPHIL ENGRAFTMENT FOLLOWING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - REPLY
Authors: CORTELAZZO S RAMBALDI A BARBUI T
Citation: S. Cortelazzo et al., EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ON THE RATE OF NEUTROPHIL ENGRAFTMENT FOLLOWING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - REPLY, Journal of clinical oncology, 13(8), 1995, pp. 2144-2144
GRANULOCYTE-COLONY-STIMULATING FACTOR FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT IN NON-HODGKINS-LYMPHOMA
Authors: CORTELAZZO S VIERO P BELLAVITA P ROSSI A BUELLI M BORLERI GM MARZIALI S BASSAN R COMOTTI B RAMBALDI A BARBUI T
Citation: S. Cortelazzo et al., GRANULOCYTE-COLONY-STIMULATING FACTOR FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT IN NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 13(4), 1995, pp. 935-941
INCREASED THROMBOXANE BIOSYNTHESIS IN ESSENTIAL THROMBOCYTHEMIA
Authors: ROCCA B CIABATTONI G TARTAGLIONE R CORTELAZZO S BARBUI T PATRONO C LANDOLFI R
Citation: B. Rocca et al., INCREASED THROMBOXANE BIOSYNTHESIS IN ESSENTIAL THROMBOCYTHEMIA, Thrombosis and haemostasis, 74(5), 1995, pp. 1225-1230
TREATMENT OF ESSENTIAL THROMBOCYTHEMIA IN PATIENTS AT LOW AND HIGH-RISK OF THROMBOSIS - A PROSPECTIVE-STUDY
Authors: FINAZZI G CORTELAZZO S RUGGERI M VESTRI O GALLI M RODEGHIERO F BARBUI T
Citation: G. Finazzi et al., TREATMENT OF ESSENTIAL THROMBOCYTHEMIA IN PATIENTS AT LOW AND HIGH-RISK OF THROMBOSIS - A PROSPECTIVE-STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 956-956
AUTOLOGOUS PBSC TRANSPLANT FOR LATE-ONSET AML AFTER MAFOSFAMIDE-PURGED AND TBI-CONTAINING AUTOLOGOUS BMT
Authors: BASSAN R CORTELAZZO S RAMBALDI A CORNELLI P BORLERI G BELLAVITA P BIONDI A BARBUI T
Citation: R. Bassan et al., AUTOLOGOUS PBSC TRANSPLANT FOR LATE-ONSET AML AFTER MAFOSFAMIDE-PURGED AND TBI-CONTAINING AUTOLOGOUS BMT, Bone marrow transplantation, 15(5), 1995, pp. 791-793
HYDROXYUREA IN ESSENTIAL THROMBOCYTOSIS - REPLY
Authors: CORTELAZZO S FINAZZI G BARBUI T
Citation: S. Cortelazzo et al., HYDROXYUREA IN ESSENTIAL THROMBOCYTOSIS - REPLY, The New England journal of medicine, 333(12), 1995, pp. 803-803
HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS
Authors: CORTELAZZO S FINAZZI G RUGGERI M VESTRI O GALLI M RODEGHIERO F BARBUI T
Citation: S. Cortelazzo et al., HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS, The New England journal of medicine, 332(17), 1995, pp. 1132-1136
G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION OF RESISTANT OR RELAPSING ACUTE LEUKEMIAS
Authors: RAMBALDI A VIERO P BASSAN R BUELLI M BELLAVITA P SPINELLI O AMARU R MICHELETTI M BORLERI GM ROSSI A CORTELAZZO S BARBUI T
Citation: A. Rambaldi et al., G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION OF RESISTANT OR RELAPSING ACUTE LEUKEMIAS, Blood, 86(10), 1995, pp. 3948-3948
POLYCYTHEMIA-VERA - THE NATURAL-HISTORY OF 1213 PATIENTS FOLLOWED FOR20 YEARS
Authors: RIUNITI O BARBUI T FINAZZI G NEGRI M SUD CMN DEGAETANO G MARCHIOLI R TOGNONI G PATRONO C LANDOLFI R DITORRETTE ON LEONI P RUPOLI S CORTELAZZO S VESTRI O TURA S FINELLI C NOCENTINI F ANGELI G DIPASQUALE A KRAMER V MARFISI R OLIVIERI M SCIULLI L SPOLTORE R CAREGGI P FERRINI PR GROSSI A LONGO G NIGUARDA O DECATALDO F GARGANTINI L BAUDO F GERARDO S POGLIANI EM MICCOLIS IR BIZZI B ROCCA B TARTAGLIONE R MANDELLI F MONTEFUSCO E SPADEA A GIOVANNI S CAROTENUTO M NOBILE M MORELLI R MOLINETTE O RESEGOTTI L VASINO MAC BARTOLO OS RODEGHIERO F RUGGERI M ROSSIFERRINI P
Citation: O. Riuniti et al., POLYCYTHEMIA-VERA - THE NATURAL-HISTORY OF 1213 PATIENTS FOLLOWED FOR20 YEARS, Annals of internal medicine, 123(9), 1995, pp. 656
RECOMBINANT VERSUS HIGH-SENSITIVITY CONVENTIONAL THROMBOPLASTIN - A RANDOMIZED CLINICAL-STUDY IN PATIENTS ON ORAL ANTICOAGULATION
Authors: FINAZZI G FALANGA A GALLI M CORTELAZZO S REMUZZI A BARBUI T
Citation: G. Finazzi et al., RECOMBINANT VERSUS HIGH-SENSITIVITY CONVENTIONAL THROMBOPLASTIN - A RANDOMIZED CLINICAL-STUDY IN PATIENTS ON ORAL ANTICOAGULATION, Thrombosis and haemostasis, 72(6), 1994, pp. 804-807
HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS WITH LUPUS ANTICOAGULANT ANDESSENTIAL THROMBOCYTHEMIA
Authors: FALANGA A OFOSU FA CORTELAZZO S DELAINI F MARZIALI S BARBUI T
Citation: A. Falanga et al., HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS WITH LUPUS ANTICOAGULANT ANDESSENTIAL THROMBOCYTHEMIA, Seminars in thrombosis and hemostasis, 20(4), 1994, pp. 324-327
ENHANCED THROMBOXANE BIOSYNTHESIS IN ESSENTIAL THROMBOCYTHEMIA - ROLEOF AGE AND PLATELET COUNT
Authors: ROCCA B LANDOLFI R CIABATTONI G CORTELAZZO S TARTAGLIONE R PATRONO C
Citation: B. Rocca et al., ENHANCED THROMBOXANE BIOSYNTHESIS IN ESSENTIAL THROMBOCYTHEMIA - ROLEOF AGE AND PLATELET COUNT, Clinical research, 42(2), 1994, pp. 10000192-10000192
HYDROXYUREA FOR THE TREATMENT OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND HIGH-RISK OF THROMBOSIS - A PROSPECTIVE, RANDOMIZED TRIAL
Authors: CORTELAZZO S FINAZZI G RUGGERI M VESTRI O GALLI M RODEGHIERO F BARBUI T
Citation: S. Cortelazzo et al., HYDROXYUREA FOR THE TREATMENT OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND HIGH-RISK OF THROMBOSIS - A PROSPECTIVE, RANDOMIZED TRIAL, Blood, 84(10), 1994, pp. 10000517-10000517
CLINICAL AND BIOLOGICAL EFFECTS OF ERYTHROPOIETIN TREATMENT OF MYELODYSPLASTIC SYNDROME
Authors: RAZZANO M CASLINI C CORTELAZZO S BATTISTEL V RAMBALDI A BARBUI T
Citation: M. Razzano et al., CLINICAL AND BIOLOGICAL EFFECTS OF ERYTHROPOIETIN TREATMENT OF MYELODYSPLASTIC SYNDROME, Leukemia & lymphoma, 10(1-2), 1993, pp. 127-134
THROMBOTIC AND HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH HEART-VALVEPROSTHESES - A MORE COMPLEX MATTER THAN PROPER PROTHROMBIN TIME RATIOS - REBUTTAL
Authors: BARBUI T CORTELAZZO S FINAZZI G VIERO P REMUZZI A
Citation: T. Barbui et al., THROMBOTIC AND HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH HEART-VALVEPROSTHESES - A MORE COMPLEX MATTER THAN PROPER PROTHROMBIN TIME RATIOS - REBUTTAL, Thrombosis and haemostasis, 70(5), 1993, pp. 879-879
RECOMBINANT TISSUE FACTOR VS CONVENTIONAL THROMBOPLASTIN FOR MONITORING ORAL ANTICOAGULANT-THERAPY - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY
Authors: FINAZZI G REMUZZI A FALANGA A GALLI M CORTELAZZO S BARBUI T
Citation: G. Finazzi et al., RECOMBINANT TISSUE FACTOR VS CONVENTIONAL THROMBOPLASTIN FOR MONITORING ORAL ANTICOAGULANT-THERAPY - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY, Thrombosis and haemostasis, 69(6), 1993, pp. 675-675
Risultati: 1-25 | 26-29